Disease: autism

Psilocybin for clinical indications: A scoping review

mycolabadmin

This comprehensive review examined over 190 research studies on psilocybin (the active compound in magic mushrooms) as a medical treatment. The research shows promise for treating depression, anxiety, substance use disorders, and chronic pain, though most studies conducted so far have been small in size. While the evidence is encouraging, researchers emphasize the need for larger, better-designed clinical trials to fully understand psilocybin’s benefits and safety profile.

Read More »

Down the rabbit hole – the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions

mycolabadmin

Psychedelic compounds like psilocybin and LSD are showing significant promise for treating various mental health conditions including depression, anxiety, and PTSD. These substances appear to work through multiple mechanisms, including inducing profound mystical experiences and increasing neuroplasticity in the brain. Research indicates that environmental and contextual factors significantly influence how effective these treatments are, and even virtual reality experiences mimicking psychedelic effects show therapeutic benefits. The field is moving toward responsible, evidence-based clinical applications of psychedelics in psychiatry.

Read More »

Effects of hallucinogenic drugs on the human heart

mycolabadmin

Hallucinogenic drugs like LSD and psilocybin affect not only the brain but also the heart. These drugs increase heart rate and contractility mainly through specific serotonin and histamine receptors. While these effects might have therapeutic potential for psychiatric conditions, prolonged use can damage heart valves and cause dangerous arrhythmias. Understanding these cardiac effects is crucial for safe medical use and treatment of overdoses.

Read More »

Impaired spatial memory in adult vitamin D deficient BALB/c mice is associated with reductions in spine density, nitric oxide, and neural nitric oxide synthase in the hippocampus

mycolabadmin

This study found that adults with vitamin D deficiency have impaired spatial memory and reduced brain structures called dendritic spines in the hippocampus, the brain region responsible for learning and memory. The researchers identified that low vitamin D decreases nitric oxide production in the brain, which is important for forming and maintaining the synaptic connections needed for memory formation. Importantly, when vitamin D was supplemented back to deficient mice, the brain’s ability to produce nitric oxide was restored, suggesting vitamin D supplementation could potentially improve cognitive function in vitamin D-deficient individuals.

Read More »

Deciphering the role of CAPZA2 in neurodevelopmental disorders: insights from mouse models

mycolabadmin

Scientists studied a gene called CAPZA2 that helps control how brain cells connect to each other. When this gene doesn’t work properly, mice had trouble learning, remembering things, and interacting socially, similar to intellectual disability in humans. The researchers found that the problem happens because the connections between brain cells become abnormal and don’t mature properly. This research helps explain why some people with mutations in this gene have developmental difficulties and could lead to new treatments.

Read More »
Scroll to Top